Last reviewed · How we verify
NCT05453838: EQUIDIA
Bioequivalence of a Diabetes Specific Tube Feed
NA trial testing oral intake of one serving of the original and new product in Postprandial Glucose Response in 22 participants. Completed in 29 November 2022.
29 November 2022
Quick facts
| Lead sponsor | Nutricia Research |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | other |
| Enrollment | 22 |
| Start date | 7 September 2022 |
| Primary completion | 29 November 2022 |
| Estimated completion | 29 November 2022 |
| Sites | 1 location across Netherlands |
Drugs / interventions tested
- oral intake of one serving of the original and new product
Conditions studied
- Postprandial Glucose Response — all drugs for Postprandial Glucose Response →
Sponsor
Nutricia Research — full company profile →
Who can join
Adults 18 to 65, any sex, with Postprandial Glucose Response. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Nutricia has a range of nutritionally complete tube feeds on the market including some specific for diabetes patients. A new product is currently under development. The aim of the present study is to assess whether the postprandial glucose response of the new product is equivalent to the postprandial glucose response of an original product. In addition, the Glycaemic Index (GI) and Glycaemic Load (GL) of the adapted product will be determined. The study will have a crossover design with healthy volunteers taking one serving of both products in a randomized order. To determine GI and GL of the adapted product subjects will also receive a reference product. Subjects will visit the study site six times: one screening visit, three study visits to measure the glucose response to the reference product and two study visits to measure the glucose response to the test and control product.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05453838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Nutricia Research trials
Trials by the same sponsor.
- NCT07243743 — Assessment of the Glycemic Responses to Nutritional Products-INQ-2526 · NA · completed
- NCT06797349 — Glin4: Assessment of the Glycemic Responses to Nutritional Products · Phase 4 · completed
- NCT06920550 — A Growth Artificial Intelligence Algorithm for leNgth and Weight Study · recruiting
- NCT06628024 — Determination of the Postprandial Amino Acid Uptake Kinetics of Yoghurt Vs Milk. · NA · completed
- NCT05731206 — Hypoallergenicity of a Hydrolyzed Protein Infant Formula · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05453838 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nutricia Research
- Last refreshed: 24 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05453838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing